Table 1.
Characteristics of the study cohort.
| Current, N = 46 | Former, N = 34 | Never, N = 33 | p-values | |
|---|---|---|---|---|
| Age* | 58.48 ± 9.96 | 61.44 ± 9.3 | 62.52 ± 11.82 | 0.198 |
| Systolic blood pressure (SBP) (mmHg)* | 131.32 ± 20.43 | 128.97 ± 13.43 | 129.54 ± 16.36 | 0.836 |
| BMI* | 26.41 ± 3.22 | 26.05 ± 3.01 | 26.00 ± 3.15 | 0.831 |
| Type of CAD (%) | 0.604 | |||
| SCAD | 11 (23.9) | 11 (32.4) | 10 (30.3) | |
| UA | 24 (52.2) | 12 (35.3) | 16 (48.5) | |
| MI | 11 (23.9) | 11 (32.4) | 7 (21.2) | |
| Gensini# | 32 (14.5, 65.5) | 45.0 (23.5,65.8) | 32.5 (20.0, 46.0) | 0.455 |
| No. of vessels (%) | 0.043 | |||
| 0 | 4 (8.7) | 0 (0) | 12 (6.1) | |
| 1 | 10 (21.7) | 5 (14.7) | 13 (39.4) | |
| 2 | 13 (28.3) | 6 (17.6) | 7 (21.2) | |
| 3 | 19 (41.3) | 23 (67.6) | 11 (33.3) | |
| History (%) | ||||
| OMI | 4 (8.7) | 9 (26.5) | 4 (12.1) | 0.076 |
| DM | 13 (28.3) | 10 (29.4) | 12 (36.4) | 0.724 |
| FLD | 9 (19.6) | 4 (11.8) | 7 (21.2) | 0.546 |
| HTN | 31 (67.4) | 21 (61.8) | 18 (54.5) | 0.51 |
| Medication (%) | ||||
| HTNdrug | 28 (60.9) | 21 (61.8) | 18 (54.5) | 0.802 |
| OAD | 10 (21.7) | 7 (20.6) | 8 (24.2) | 0.934 |
| Statin | 15 (32.6) | 11 (32.4) | 13 (39.4) | 0.782 |
| Laboratory data | ||||
| TC (mmol/L)* | 3.97 ± 1.01 | 3.6 ± 0.63 | 3.99 ± 1.27 | 0.176 |
| TG (mmol/L)* | 1.92 ± 1.75 | 1.46 ± 0.61 | 1.4 ± 0.59 | 0.103 |
| HDL-C (mmol/L)* | 0.89 ± 0.19 | 0.93 ± 0.21 | 0.97 ± 0.18 | 0.235 |
| LDL-C (mmol/L)* | 2.28 ± 0.75 | 2.03 ± 0.58 | 2.37 ± 1.1 | 0.218 |
| hsCRP (mg/L)# | 2.02 (1.04, 3.56) | 1.78 (0.48, 4.48) | 1.86 (0.54, 7.35) | 0.712 |
| cTnI (ng/ml)# | 0.011 (0.000,0.037) | 0.012 (0.000,0.075) | 0.003 (0.000, 0.065) | 0.706 |
Values are presented as *mean ± SD, #median (IQR).
One-way ANOVA and Kruskal-Wallis H-test were employed in cases of continuous data. Categorical variables were compared by the χ2 test or Fisher's exact test.
SCAD, stable coronary artery disease; UA, unstable angina; MI, myocardial infarction; No. of vessels, number of stenosed vessels;l OMI, old myocardial infarction; DM, diabetes; FLD, fatty liver disease; HTN, hypertension; OAD, oral antidiabetic drugs.